A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

Avoid these weight loss journey pitfalls with our expert tips.

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

The UK pharmaceutical giant AstraZeneca is doubling down on its commitment to the Chinese drugmaker CSPC Pharmaceutical Group ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

Prediabetes can improve without weight loss when fat distribution and metabolic hormones shift in healthier ways. Many people believe that losing weight is the primary way to reduce the risk of ...

If you’re looking to create a healthier lifestyle, look no further than the power of running. Movement makes up a portion of the weight loss puzzle, and with our new Running for Weight Loss program, ...

Getting (and staying) fit isn’t cheap. In A Nutshell Americans trying to lose weight say they spent an average of $12,308 in ...